1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "287204-45-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-103274
    PD180970

    Bcr-Abl Src c-Kit Apoptosis Cancer Neurological Disease
    PD180970 is a highly potent and ATP-competitive p210 Bcr-Abl kinase inhibitor, with an IC50 of 5 nM for inhibiting the autophosphorylation of p210 Bcr-Abl. PD180970 also inhibits Src and KIT kinase with IC50s of 0.8 nM and 50 nM, respectively. PD180970 indcues apoptosis of K562 leukemic cells, and can be used for chronic myelogenous leukemia research.